The objectives of this programme were to scale-up the targeted mass drug administration strategy regionally, and measure its effect on the incidence of clinical malaria in eastern Karen/Kayin state, Myanmar, a difficult-to-access hilly and forested area with complex political and geographical landscapes, where malaria transmission is seasonal and where artemisinin resistant Plasmodium falciparum is prevalent.